Topelia is focused on the rapid and efficient development of antiviral therapeutics targeting coronavirus infections

Covid-19 The Ongoing Health Risk

While most patients diagnosed with COVID-19 develop only mild to moderate disease, approximately 25% will progress to severe/critical disease state requiring medical intervention and mechanical ventilation with poor prognosis for disease resolution in severe or critical cases. These sorts of outcomes are particularly seen in the elderly and those with co-morbidities⁴.